CEST成像揭示成人胶质瘤放疗后肿瘤特异性分子变化
这项前瞻性研究纳入33例胶质瘤患者(26例胶质母细胞瘤、7例IDH突变胶质瘤),共完成81次纵向CEST MRI扫描,分析放疗前至放疗后七个月内正常脑组织与肿瘤区域的CEST对比变化。结果显示正常脑组织在高剂量放疗后CEST对比无显著变化,而肿瘤区域CEST对比随治疗反应改变,APTw信号在放疗后四周即可区分肿瘤生长与假性进展。
要点
- 正常脑组织在高剂量放疗后CEST对比无显著变化。
- 肿瘤区域CEST对比随治疗反应改变,APTw信号在放疗后四周出现方向相反的Trend。
- CEST MRI有潜力在后期区分假性进展与肿瘤生长。
核心结论
- CEST对比可揭示胶质瘤放疗后肿瘤特异性分子变化。
- 这些早期变化支持CEST MRI在后期区分假性进展与肿瘤生长的潜力。
研究设计与样本
- 前瞻性研究纳入33例胶质瘤患者,其中26例胶质母细胞瘤、7例IDH突变胶质瘤。
- 共完成81次纵向CEST MRI扫描,覆盖放疗前至放疗后七个月。
- CEST MRI包括APTw信号的不对称分析,并用多池Lorentzian拟合量化酰胺信号、ssMT信号和rNOE信号。
- 采用累积直方图和贝叶斯线性多水平模型分析正常脑组织与肿瘤的CEST对比变化。
主要发现
- 正常脑组织在高剂量放疗后任何CEST对比均无显著变化。
- 肿瘤区域CEST对比随治疗反应改变。
- APTw信号在放疗后四周对肿瘤生长与假性进展显示中等程度的相反趋势:疾病稳定为-0.08/月(-0.15至-0.01),疾病进展为+0.18/月(0.07至0.29),假性进展为-0.53/月(-0.65至0.42)。
临床怎么用
- CEST MRI可作为放疗后胶质瘤反应评估的分子影像工具,辅助鉴别假性进展与肿瘤生长。
- APTw信号在放疗后四周的早期变化值得关注,可用于后续随访判断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Response assessment after radiotherapy (RT) of gliomas remains challenging due to radiation-induced reactions that mimic tumor growth (pseudoprogression, PsPD). Unlike standard anatomical MRI, Chemical Exchange Saturation Transfer (CEST) MRI offers molecular image contrasts that could differentiate tumor growth from PsPD. Our aim was to quantify the influence of radiation dose on CEST contrasts in both healthy-appearing brain tissues and tumor tissues. METHODS: This prospective study enrolled 33 glioma patients (26 glioblastoma, 7 IDH-mutant glioma). In total, 81 longitudinal CEST MRI scans were performed before RT until seven months thereafter. CEST MRI included asymmetry analysis of the amide proton transfer-weighted (APTw) signal, and a multipool Lorentzian fitting approach was used to quantify the amide signal, ssMT signal and rNOE signal. CEST contrast changes were analyzed in normal-appearing brain tissues and tumor by cumulative histograms and based on Bayesian linear multilevel models. RESULTS: Normal-appearing brain tissues did not exhibit significant changes in any CEST contrasts after high-dose radiation. Conversely, the CEST contrasts changed in the tumor region of glioma patients according to their response to treatment. Particularly the APTw-signal demonstrated moderate opposing trends for tumor growth versus PsPD as early as four weeks after RT (stable disease: -0.08/month [-0.15 to -0.01], progressive disease: +0.18/month [0.07 - 0.29], PsPD: -0.53/month [-0.65 to 0.42]). CONCLUSIONS: Our findings indicate that CEST contrasts reveal tumor-specific molecular changes in gliomas following RT. These early changes support the potential of CEST MRI to differentiate PsPD from tumor growth at later time points.
引用
- Regnery S, Doeberitz NVK, Kroh F, et al. Chemical exchange saturation transfer (CEST) imaging reveals tumor-specific molecular changes in adult gliomas after radiotherapy. Radiother Oncol. 2026. PMID: 41916447. doi:10.1016/j.radonc.2026.111513
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。